Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Urologic Neoplasms 2Stomach Neoplasms 2Brain Neoplasms 2beta-Thalassemia 1Urinary Bladder Neoplasms 1Supratentorial Brain Tumor Surgery 1Strabismus 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Post-operative Residual Curarization 1Obesity 1Neuromuscular Blockade 1Neoplasms 1Myasthenia Gravis 1Hepatoblastoma 1Endobronchial Metastases 1Emergence Delirium 1Delayed Emergence from Anesthesia 1

Interventions

rozanolixizumab 10zilucoplan 8efgartigimod alfa 8Rituximab 7Cyclophosphamide 7telitacicept 6fludarabine 6eculizumab 5Prednisone 5ravulizumab 4Pyridostigmine Bromide 4Immunoglobulins, Intravenous 4Hizentra 4Tacrolimus 3Mycophenolic Acid 3HBM9161 3Amifampridine 3thymoglobulin 2inebilizumab 2Prednisolone 2Exercise 2tofacitinib 1tocilizumab 1talquetamab 1satralizumab 1sargramostim 1rhoA GTP-Binding Protein 1remibrutinib 1prednylidene 1iscalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Myasthenia Gravis × Sugammadex × Clear all
NCT06436768 2025-04-02

Efficacy and Safety of Sugammadex in Thoracoscopy Thymectomy for Chinese Adults With Myasthenia Gravis

Beijing Tongren Hospital

Phase NA Completed
62 enrolled

Myasthenia Gravis, Delayed Emergence from Anesthesia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡